No article in the knowledge graph for Clonix yet.
Who is Clonix?
Clonix is a Brazil-based biotechnology and clinical diagnostics company that develops, manufactures, and distributes diagnostic reagents and solutions for medical, laboratory, and research use.
- Production of in vitro diagnostic reagents and kits for clinical laboratories (clinical diagnostics).
- Solutions for molecular biology and microbiology workflows used in research and diagnostic contexts (life sciences tools).
- Quality control materials and calibrators to support laboratory testing reliability (laboratory quality management).
- Technical support and training for implementation and use of diagnostic products in healthcare and research institutions (laboratory services).
- Distribution of diagnostic and laboratory products across Brazil through partnerships with healthcare providers and labs (healthcare supply distribution).
Show more
More About
Clonix operates in the biotechnology and clinical diagnostics domain, with a focus on supplying reagents, kits, and related solutions for laboratories, hospitals, and research institutions in Brazil. Its portfolio centers on in vitro diagnostics, where its products are integrated into clinical workflows for areas such as clinical chemistry, hematology, immunology, microbiology, and molecular biology. These offerings support routine diagnostic testing and specialized assays used for patient diagnosis, monitoring, and screening.
The company’s reagent and kit lines align with common diagnostic platforms and methodologies, including spectrophotometric analyzers, immunoassay systems, culture-based microbiology methods, and nucleic acid–based techniques used in molecular diagnostics. Products are typically designed to comply with regulatory standards for in vitro diagnostic use and to be compatible with equipment deployed in Brazilian clinical laboratories. This includes integration into automated analyzers where applicable, as well as use in semi-automated or manual workflows in smaller labs.
Clonix also supplies quality control materials and calibrators that laboratories apply within established quality management frameworks such as internal quality control programs and participation in external proficiency testing schemes. These materials help labs validate assay performance, monitor analytical precision and accuracy, and document compliance with accreditation requirements. Such products are relevant for labs operating under standards comparable to ISO 15189 or national accreditation programs, where traceability and documentation of analytical performance are required.
Beyond reagents, the company provides technical support and training to help institutions deploy and maintain its diagnostic solutions. This typically involves guidance on assay validation, lot-to-lot verification, instrument compatibility, workflow configuration, troubleshooting, and adherence to manufacturer instructions for use. Technical teams interface with laboratory managers, biomedical scientists, and clinicians to align product use with clinical protocols and regulatory expectations.
In the enterprise and institutional context, Clonix is positioned as a supplier within the healthcare diagnostics and life sciences tools ecosystem. Its offerings map to marketplace categories such as in vitro diagnostic reagents, clinical chemistry and immunoassay consumables, microbiology and molecular biology reagents, and laboratory quality control materials. Organizations evaluating diagnostic supply chains may classify Clonix alongside other regional and global diagnostic reagent manufacturers when structuring vendor portfolios, assessing product compatibility with installed analyzers, and managing procurement and logistics for hospital and reference laboratory networks.
Our description of Clonix. Updated February 2026.
